natgillin/translations-raw huggingface dataset:
Check you still have medicine left.
Preverite, ali je v njem še dovolj zdravila.
Check your blood sugar
Preverjajte nivo krvnega sladkorja.
Check your blood sugar and then inject your next dose at the usual time.
Izmerite krvni sladkor in nato injicirajte naslednji odmerek ob običajnem času.
Check your blood sugar frequently.
Pogosto si kontrolirajte krvni sladkor.
Check your child’s age and weight to see if Viread 123 mg tablets are suitable, see Children and adolescents.
Preverite starost in telesno maso svojega otroka, da se prepričate, ali je zdravilo Viread 123 mg tablete primerno, glejte Otroci in mladostniki.
Check your child’s age and weight to see if Viread 163 mg tablets are suitable, see Children and adolescents.
Preverite starost in telesno maso svojega otroka, da se prepričate, ali je zdravilo Viread 163 mg tablete primerno, glejte Otroci in mladostniki.
Check your child’s age and weight to see if Viread 204 mg tablets are suitable, see Children and adolescents.
Preverite starost in telesno maso svojega otroka, da se prepričate, ali je zdravilo Viread 204 mg tablete primerno, glejte Otroci in mladostniki.
check your pen and the needle are working properly. make sure that you get the correct insulin dose.
da boste preverili pravilno delovanje peresnika in igle. da boste zagotovili injiciranje pravilnega odmerka insulina.
Check your skin regularly whilst taking dabrafenib.
V času jemanja dabrafeniba si redno pregledujte kožo.
Check your skin regularly whilst taking Tafinlar
Med jemanjem zdravila Tafinlar si redno pregledujte kožo.
Check your syringe contains 1 ml of water for injections.
Preverite, ali brizga vsebuje 1 ml vode za injekcije.
Checklist for monitoring inadequate product disposal to ensure healthcare professionals understand the dangers of inappropriate handling and accidental exposure to the IONSYS system.
Kontrolni seznam za spremljanje neustreznega odstranjevanja sistema zaradi zagotavljanja, da zdravstveni delavci razumejo nevarnosti nenamerne izpostavljenosti sistemu Ionsys in nepravilnega ravnanja z njim.
Checks for digestive bleeding
Preiskave za ugotavljanje krvavitev iz prebavil
cheese, whole milk, whole-milk dairy products
ir, neposneto mleko, mlečni izdelki iz neposnetega mleka;
Cheese, whole milk, whole-milk dairy products, yogurt, chocolate
ir, neposneto mleko, mlečni izdelki iz neposnetega mleka, jogurt, čokolada
cheilitis, dyspepsia, constipation,
heilitis, dispepsija, zaprtje, gingivitis
cheilitis, dyspepsia, constipation, gingivitis
heilitis, dispepsija, zaprtje, gingivitis
Chelation of iron, especially through its ring-opened metabolite thus reducing the iron- dependent oxidative stress causing anthracycline-induced cardiotoxicity.
Kelacija železa, zlasti preko odprtega presnovka z obročem, s čimer se zmanjša od železa odvisni oksidativni stres, ki je odgovoren za kardiotoksičnost antraciklinov.
Chemical and physical and microbial stability of unused, undiluted product remaining in the vial has been demonstrated for up to 28 days when stored below 25 ºC. Other in-use storage times and conditions are the responsibility of the user.
Neporabljeneno in nerazredčeneno zdravilo, ki ostane v viali, je kemijsko, fizikalno in mikrobiološko stabilno 28 dni pri temperaturi do 25 °C. Drugačni časi in pogoji shranjevanja zdravila po prvem odpiranju so odgovornost uporabnika.
Chemical and physical in use stability has been demonstrated for 24 hours at 25°C.
Raztopina ostane kemično in fizikalno stabilna 24 ur, če jo hranimo pri temperaturi do 25°C.
Chemical and physical in use stability has been demonstrated for 60 days at 37C.
Kemična in fizikalna stabilnost med uporabo znaša 60 dni pri 37 °C.
Chemical and physical in use stability of the reconstituted and diluted solution has been demonstrated for 24 hours at room temperature (at or below 25°C).
Kemična in fizikalna stabilnost pripravljene in razredčene raztopine med uporabo sta dokazani za 24 ur pri sobni temperaturi (25 °C ali manj).
Chemical and physical in use stability of the reconstituted solution has been demonstrated for 24 hours at 25 °C. From a microbiological point of view, the product should be used as soon as possible but within 3 hours of reconstitution and dilution.
Pokazali so, da je rekonstituirana raztopina zdravila Remicade kemično in fizikalno stabilna 24 ur pri 25 °C. Z mikrobiološkega stališča pa morate raztopino uporabiti čim prej, najpozneje pa v roku 3 ur po rekonstituciji in redčenju.
Chemical and physical in use stability of the reconstituted solution has been demonstrated for 24 hours at 25C.
Pokazali so, da je rekonstituirana raztopina kemično in fizikalno stabilna 24 ur pri 25 C.
Chemical and physical in use stability of the reconstituted solution has been demonstrated for 24 hours at 25C.
Pokazali so, da je rekonstituirana raztopina kemično in fizikalno stabilna 24 ur pri 25C.
Chemical and physical in-use stability after dilution has been demonstrated for 24 hours when stored at 2°C -8°C and for 4 hours when stored at 25°C.
Dokazano je bilo, da je po redčenju raztopina kemijsko in fizikalno stabilna 24 ur, če je bila hranjena pri 2 °C–8 °C, in 4 ure, če je bila hranjena pri 25 °C.
Chemical and physical in-use stability after dilution has been demonstrated for 24 hours when stored at 2°C-8°C and for 4 hours when stored at 25°C.
Dokazano je bilo, da je po redčenju raztopina kemijsko in fizikalno stabilna 24 ur, če je bila hranjena pri 2 °C –8 °C in 4 ure, če je bila hranjena pri 25 °C.
Chemical and physical in-use stability after dilution in 0.9 % sodium chloride or 5% glucose solution has been demonstrated for 36 hours at 25°C and 2 °C to 8 °C.
Kemična in fizikalna stabilnost po razredčitvi v 0,9 % raztopini natrijevega klorida ali 5 % raztopini glukoze je bila dokazana za 36 ur pri 25 °C in 2 °C do 8 °C.
Chemical and physical in-use stability after dilution in 0.9 % sodium chloride or 5% glucose solution has been demonstrated for 36 hours at 25°C and 2 °C to 8 °C.
Kemična in fizikalna stabilnost po razredčitvi v 0,9% raztopini natrijevega klorida ali 5 % raztopini glukoze je bila dokazana za 36 ur pri 25 °C in 2 °C do 8 °C.
Chemical and physical in-use stability after dilution in glucose 5% or sodium chloride 9 mg/ml (0.9%) solution for injection has been demonstrated for:
Kemijsko in fizikalno stabilnost med uporabo, po redčenju v 5-odstotni raztopini glukoze ali 0,9- odstotni raztopini natrijevega klorida (9 mg/ml) za injiciranje so dokazali za:
Chemical and physical in-use stability after reconstitution and subsequent dilution in the diluent has been demonstrated for 4 hours when stored at 2 to 8C.
Dokazali so, da je zdravilo po rekonstituciji in redčenju v vehiklu kemično in fizikalno stabilno do 4 ure, če se shranjuje pri temperaturi 2 do 8 °C.
Chemical and physical in-use stability after reconstitution has been demonstrated for 8 hours when stored at 2°C-8°C.
Dokazano je bilo, da je rekonstituirana raztopina kemijsko in fizikalno stabilna 8 ur, če je bila hranjena pri 2 °C–8 °C.
Chemical and physical in-use stability has been demonstrated for 1 hour at ambient temperature (15°C-30°C).
Kemična in fizikalna stabilnost med uporabo sta dokazani za 1 uro temperature okolice (15°C-30°C).
Chemical and physical in-use stability has been demonstrated for 10 days at 2°C – 8°C or 96 hours at or below 27°C.
Kemična in fizikalna stabilnost med uporabo sta bili dokazani za 10 dni pri temperaturi od 2 °C – 8 °C ali 96 ur pri temperaturi do vključno 27 °C.
Chemical and physical in-use stability has been demonstrated for 10 days at 2C – 8°C or 96 hours at or below 27°C.
Kemična in fizikalna stabilnost med uporabo sta dokazani za 10 dni pri temperaturi od 2 C – 8 °C in za 96 ur pri temperaturi do vključno 27 °C.
Chemical and physical in-use stability has been demonstrated for 14 days at 20°C - 25°C when stored in the outer carton to protect from light.
Kemična in fizikalna stabilnost po prvem odprtju sta bili dokazani za 14 dni pri 20 °C do 25 °C, če je zdravilo shranjeno v zunanji ovojnini za zagotovitev zaščite pred svetlobo.
Chemical and physical in-use stability has been demonstrated for 2 days at 2 °C – 8 °C.
Kemijsko in fizikalno stabilnost med uporabo so dokazali za 2 dni pri 2 °C - 8 °C.
Chemical and physical in-use stability has been demonstrated for 2 hours at 25ºC. From a microbiological point of view, unless the method of reconstitution precludes the risk of microbial contamination, the product should be used immediately.
Kemijsko in fizikalno stabilnost v času uporabe so dokazali za 2 uri pri 25 ºC. Z mikrobiološkega stališča je treba zdravilo uporabiti takoj, razen če metoda rekonstitucije izključuje tveganje kontaminacije z mikrobi.
Chemical and physical in-use stability has been demonstrated for 24 hours at 2 to 8°C and 25ºC.
Kemična in fizikalna stabilnost med uporabo sta dokazani za 24 ur pri temperaturi 2 °C – 8 °C in
Chemical and physical in-use stability has been demonstrated for 24 hours at 2 to 8°C and 25ºC.
Kemična in fizikalna stabilnost med uporabo sta dokazani za 24 ur pri temperaturi 2 °C – 8 °C in 25 °C.
Chemical and physical in-use stability has been demonstrated for 24 hours at 2 to 8ºC and 25ºC. From a microbiological point of view, the product should be used immediately.
Kemična in fizikalna stabilnost med uporabo sta dokazani za 24 ur pri temperaturi 2 °C – 8 °C in 25 °C. Iz mikrobiološkega stališča morate zdravilo porabiti takoj.
Chemical and physical in-use stability has been demonstrated for 24 hours at 2 to 8ºC and 25ºC. From a microbiological point of view, the product should be used immediately.
Kemična in fizikalna stabilnost med uporabo sta dokazani za 24 ur pri temperaturi 2 °C – 8 °C in 25 °C. Iz mikrobiološkega stališča, morate zdravilo porabiti takoj.
Chemical and physical in-use stability has been demonstrated for 24 hours at 2 to 8C and 25C.
Kemična in fizikalna stabilnost med uporabo sta dokazani za 24 ur pri temperaturi 2 °C – 8 °C in
Chemical and physical in-use stability has been demonstrated for 24 hours at 21C to 81C under protection from light.
Raztopina ostane kemično in fizično stabilna 24 ur pri temperaturi od 2 °C do 8 °C, zaščitena pred svetlobo.
Chemical and physical in-use stability has been demonstrated for 24 hours at 25°C under normal light conditions and at 2°C-8°C when protected from light.
Kemična in fizikalna stabilnost zdravila med uporabo je bila dokazana za čas 24 ur pri temperaturi 25 °C v pogojih normalne osvetlitve ter pri temperaturi od 2 °C do 8 °C, kadar je zdravilo zaščiteno pred svetlobo.
Chemical and physical in-use stability has been demonstrated for 24 hours at 2°C to 8°C.
Zdravilo je med uporabo kemično in fizikalno stabilno 24 ur pri temperaturi 2 °C do 8 °C.
Chemical and physical in-use stability has been demonstrated for 24 hours at 2°C to 8°C. Solvent for solution for infusion:
Kemična in fizikalna stabilnost med uporabo sta bili dokazani za 24 ur pri temperaturi med 2 °C in 8 °C.
Chemical and physical in-use stability has been demonstrated for 24 hours at 2°C – 8°C or 4 hours at or below 27°C.
Kemična in fizikalna stabilnost med uporabo sta bili dokazani za 24 ur pri temperaturi od 2 °C – 8 °C ali 4 ure pri temperaturi do vključno 27 °C.
Chemical and physical in-use stability has been demonstrated for 24 hours at 2C – 8°C or 4 hours at or below 27°C.
Kemična in fizikalna stabilnost med uporabo sta dokazani za 24 ur pri temperaturi od 2 C – 8 °C in za 4 ure pri temperaturi do vključno 27 °C.
Chemical and physical in-use stability has been demonstrated for 24 hours at 30°C.
Kemična in fizikalna stabilnost med uporabo sta dokazani za 24 ur pri temperaturi 30 °C.
Chemical and physical in-use stability has been demonstrated for 24 hours at temperatures up to 25° C for product mixed with the diluents mentioned in 6.6 and stored in glass or PVC bags.
Dokazali so, da je raztopina med uporabo kemijsko in fizikalno stabilna 24 ur pri 25 °C, če je bilo zdravilo razredčeno z raztopinami, ki so navedene v poglavju 6.6 in shranjena v steklenicah ali PVC vrečah.
Chemical and physical in-use stability has been demonstrated for 24 hours stored at 2°C - 8°C and 4 hours stored at ≤30°C.
Kemična in fizikalna stabilnost med uporabo sta dokazani za 24 ur v primeru shranjevanja pri temperaturi 2 °C – 8 °C in 4 ure v primeru shranjevanja pri sobni temperaturi (≤ 30 °C).
Chemical and physical in-use stability has been demonstrated for 27 days at 2ºC – 8ºC.
Med uporabo je zdravilo kemično in fizikalno stabilno 27 dni pri temperaturi med 2 in 8 ºC.
Chemical and physical in-use stability has been demonstrated for 28 days at 25C.
Dokazano je bilo, da je kemična in biološka stabilnost po odprtju 28 dni pri 25 °C.
Chemical and physical in-use stability has been demonstrated for 3 hours at 23°C. From a microbiological point of view, the product should be used immediately.
Kemično in fizikalno stabilnost med uporabo so dokazovali 3 ure pri 23°C. Z mikrobiološkega stališča je treba zdravilo takoj uporabiti.
Chemical and physical in-use stability has been demonstrated for 3 hours at a temperature not above 30°C. From a microbiological point of view, unless the method of reconstitution precludes the risk of microbial contamination, the product should be used immediately.
Kemijska in fizikalna stabilnost med uporabo sta bili dokazani za obdobje 3 ur pri temperaturi do 30 °C. Z mikrobiološkega vidika je treba razredčeno zdravilo nemudoma uporabiti, razen če način rekonstitucije izključi tveganje mikrobne kontaminacije.
Chemical and physical in-use stability has been demonstrated for 3 hours at a temperature of 21°C.
Kemijska in fizikalna stabilnost med uporabo je dokazana za 3 ure pri temperaturi 21 °C.
Chemical and physical in-use stability has been demonstrated for 36 hours at 2 – 8 °C.
Kemijska in fizikalna stabilnost je bila dokazana med uporabo 36 ur pri 2-8 ° C.
Chemical and physical in-use stability has been demonstrated for 36 hours at 2 – 8 °C.
Pokazali so kemijsko in fizikalno stabilnost med uporabo za 24 ur pri 2–8 °C.
Chemical and physical in-use stability has been demonstrated for 4 hours at 25°C. From a microbiological point of view, the medicinal product should be used immediately.
Kemijsko in fizikalno stabilnost med uporabo so dokazali za 4 ure pri 25 °C. Z mikrobiološkega stališča je treba zdravilo uporabiti takoj.
Chemical and physical in-use stability has been demonstrated for 4 hours at 25°C. From a microbiological point of view, the medicine should be used immediately.
Kemijska in fizikalna stabilnost med uporabo je bila dokazana za 4 ure pri 25 °C. Z mikrobiološkega stališča je treba zdravilo uporabiti takoj.
Chemical and physical in-use stability has been demonstrated for 48 hours at 2°C-8°C and at 25°C after dilution in 100 ml sodium chloride 9 mg/ml (0.9%) solution for injection or 5% w/v glucose solution (minimal concentration: 3 mg/100 ml; maximal concentration: 4 mg/100 ml).
Med uporabo je bila dokazana kemična in fizikalna stabilnost 48 ur, pri temperaturi od 2°C-8°C in pri temperaturi 25°C po redčenju v 100 ml raztopine natrijevega klorida 9 mg/ml (0.9 %) za injiciranje ali 5 % m/V raztopini glukoze (minimalna koncentracija: 3 mg/100 ml; maksimalna koncentracija: 4 mg/100 ml).
Chemical and physical in-use stability has been demonstrated for 48 hours at 2C - 8C after reconstitution.
Dokazali so, da je rekonstituirano zdravilo med uporabo kemijsko in fizikalno stabilno 48 ur pri temperaturi od 2 C do 8 C.
Chemical and physical in-use stability has been demonstrated for 6 hours at room temperature (between approximately 20C – 25°C).
Ugotovljena je bila kemijska in fizikalna stabilnost pripravljene suspenzije 6 ur pri sobni temperaturi (med približno 20 C – 25 °C).
Chemical and physical in-use stability has been demonstrated for 6 hours at temperatures not above 25C after reconstitution.
Dokazali so, da je rekonstituirano zdravilo med uporabo kemijsko in fizikalno stabilno 6 ur pri temperaturi do 25C.
Chemical and physical in-use stability has been demonstrated for 6 hours at temperatures of up to 25C after reconstitution.
Dokazali so, da je rekonstituirano zdravilo med uporabo kemijsko in fizikalno stabilno 6 ur pri temperaturi do 25 C.
Chemical and physical in-use stability has been demonstrated for 8 hours at 2°C - 8°C and protected from light.
Ugotovljeno je bilo, da je raztopina kemično in fizikalno stabilna 8 ur, če je shranjena pri temperaturi od 2 °C – 8 °C in zaščitena pred svetlobo.
Chemical and physical in-use stability has been demonstrated for 8 hours at 2C - 8C.
Kemijska in fizikalna stabilnost med uporabo je bila dokazana za 8 ur pri 2 C - 8 C.
Chemical and physical in-use stability has been demonstrated for 8 hours at room temperature.
Dokazano je, da je raztopina pri sobni temperaturi kemijsko in fizikalno stabilna 8 ur.
Chemical and physical in-use stability has been demonstrated for 96 hours at 25 °C
Dokazano je bilo, da je raztopina, pripravljena za uporabo, kemijsko in fizikalno stabilna 96 ur pri temperaturi 25 °C.
Chemical and physical in-use stability has been demonstrated for 96 hours at 25°C when protected from light and diluted as described above.
Kemična in fizikalna stabilnost med uporabo sta dokazani za 96 ur pri temperaturi 25 °C, če je zdravilo zaščiteno pred svetlobo in razredčeno, kot je opisano zgoraj.
Chemical and physical in-use stability has been demonstrated for the diluted medicinal product as follows: protected from light in polyethylene or polyvinylchloride infusion bag: for up to 6 days in a refrigerator (2°C-8°C) or for up to 24 hours at 25°C; exposed to light in polyethylene or polyvinylchloride infusion set for up to 1 hour at 25°C.
Kemijska in fizikalna stabilnost med uporabo sta bili dokazani za redčeno zdravilo, in sicer: zaščiteno pred svetlobo v polietilenski ali polivinilkloridni infuzijski vreči do 6 dni v hladilniku (od 2 °C do 8 °C) ali do 24 ur pri 25 °C , izpostavljeno svetlobi v polietilenskem ali polivinilkloridnem infuzijskem kompletu do 1 uro pri 25 °C.
Chemical and physical in-use stability has been demonstrated for the times and solutions shown in the above table.
Kemična in fizikalna stabilnost zdravila med uporabo je bila dokazana za čas in vrste raztopin, ki so navedene v zgornji preglednici.
Chemical and physical in-use stability has been demonstrated for up to 1 hour at a temperature between 23°C to 27°C.
Kemijska in fizikalna stabilnost med uporabo je bila dokazana za do 1 uro pri temperaturi med 23 °C in 27 °C.
Chemical and physical in-use stability has been demonstrated for up to 24 hours at 2 - 8ºC when dilution is performed under controlled and validated aseptic conditions.
Kemična in fizikalna stabilnost med uporabo sta dokazani za 24 ur pri temperaturi od 2-8 ºC, če je bila raztopitev izvedena pod kontroliranimi in validiranimi aseptičnimi pogoji.
Chemical and physical in-use stability has been demonstrated for up to 48 hours at 25°C.
Dokazana je bila 48-urna kemična in fizikalna stabilnost med uporabo pri 25 °C.
Chemical and physical in-use stability have been demonstrated for 24 hours stored at 2°C - 8°C and 4 hours stored at ≤30°C.
Kemična in fizikalna stabilnost med uporabo sta dokazani za 24 ur v primeru shranjevanja pri temperaturi 2 °C – 8 °C in 4 ure v primeru shranjevanja pri sobni temperaturi (≤ 30 °C).
Chemical and physical in-use stability have been demonstrated for 96 hours at 25°C when protected from light and diluted as described above.
Kemična in fizikalna stabilnost med uporabo sta dokazani za 96 ur pri temperaturi 25°C, če je zdravilo zaščiteno pred svetlobo in razredčeno, kot je opisano zgoraj.
Chemical and physical in-use stability of Cyramza in sodium chloride 9 mg/ml (0.9%) solution for injection has been demonstrated for 24 hours at 2 ºC to 8 ºC or for 4 hours at 25 ºC. From a microbiological point of view, the product should be used immediately.
Dokazano je bilo, da je zdravilo Cyramza v 9 mg/ml (0,9 %) raztopini natrijevega klorida za injiciranje med uporabo kemično in fizikalno stabilno: 24 ur pri temperaturi 2 ºC do 8 ºC ali 4 ure pri temperaturi 25 ºC. Z mikrobiološkega vidika je treba zdravilo uporabiti takoj.
Chemical and physical in-use stability of infusion solution of pemetrexed was demonstrated for 3 days at room temperature and 21 days at refrigerated temperature.
Kemijsko in fizikalno obstojnost raztopin pemetrekseda za infundiranje so pokazali za 3 dni na sobni temperaturi in 21 dni v hladilniku.
Chemical and physical in-use stability of infusion solutions of Pemetrexed Sandoz has been demonstrated for 4 days at 2°C to 8°C and for 2 days below 25°C.
Kemična in fizikalna stabilnost raztopine za infundiranje zdravila Pemetreksed Sandoz med uporabo je dokazana za 4 dni pri temperaturi 2°C do 8°C in 2 dnipri temperaturi do 25°C.
Chemical and physical in-use stability of reconstituted and infusion solutions of Pemetrexed Hospira powder for concentrate for solution for infusion has been demonstrated for up to 24 hours after reconstitution of the original vial when stored below 25°C.
Kemijsko in fizikalno obstojnost za uporabo rekonstituiranih raztopin in raztopin za infundiranje zdravila Pemetreksed Hospira prašek za koncentrat za raztopino za infundiranje so pokazali za 24 ur v hladilniku, po pripravi originalne viale, shranjene pri temperaturi do 25 °C.
Chemical and physical in-use stability of reconstituted and infusion solutions of pemetrexed were demonstrated for 24 hours at refrigerated temperature.
Kemična in fizikalna stabilnost med uporabo rekonstituiranih raztopin pemetrekseda in raztopin pemetrekseda za infundiranje sta dokazani za 24 ur v hladilniku.
Chemical and physical in-use stability of reconstituted solutions in the vial, syringe or intravenous bag has been demonstrated for 24 hours at 2°C - 8°C or for 4 hours at 25°C. The elapsed time from reconstitution to administration should not exceed 24 hours.
Kemična in fizikalna stabilnost med uporabo rekonstituiranih raztopin v viali, brizgi ali intravenski vrečki je dokazana za 24 ur pri 2 °C – 8 °C ali za 4 ure pri 25 °C. Čas od rekonstitucije do uporabe ne sme preseči 24 ur.
Chemical and physical in-use stability of the diluted product stored in PVC bags has been demonstrated for 24 hours at 30 °C and at 2-8 °C. From a microbiological point of view, unless the method of dilution precludes the risk of microbial contamination, the product should be used immediately.
Kemična in fizikalna stabilnost razredčenega zdravila med uporabo, shranjenega v PVC vrečkah, sta bili dokazani za obdobje 24 ur pri temperaturi 30 °C in pri od 2 do 8 °C. Z mikrobiološkega stališča je zdravilo treba uporabiti takoj, razen, če metoda redčenja izključuje mikrobiološko kontaminacijo.
Chemical and physical in-use stability of the diluted product stored in PVC bags has been demonstrated for 24 hours at 30 °C and at 2-8 °C. From a microbiological point of view, unless the method of dilution precludes the risk of microbial contamination, the product should be used immediately.
Kemična in fizikalna stabilnost razredčenega zdravila med uporabo, shranjenega v PVC vrečkah, sta bili dokazani za obdobje 24 ur pri temperaturi 30 °C in pri od 2 do 8 °C. Z mikrobiološkega stališča je zdravilo treba uporabiti takoj, razen, če metoda redčenja izključuje tveganje za mikrobiološko kontaminacijo.
Chemical and physical in-use stability of the diluted solution for infusion has been demonstrated for 24 hours at 2 °C to 8 °C. From a microbiological point of view, the product should be used immediately.
Kemična in fizikalna stabilnost razredčene raztopine za infundiranje med uporabo sta bili dokazani za obdobje 24 ur pri temperaturi od 2 °C do 8 °C. Z mikrobiološkega stališča je zdravilo treba uporabiti takoj.
Chemical and physical in-use stability of the diluted solution for infusion has been demonstrated for 24 hours at 2 °C to 8 °C. From a microbiological point of view, the product should be used immediately.
Razredčena raztopina za infundiranje ostane kemično in fizikalno stabilna še 24 ur pri temperaturi od 2 °C do 8 °C. Z mikrobiološkega vidika morate zdravilo porabiti takoj.